Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-10-01
著者
-
ENOMOTO Nobuyuki
First Department of Internal Medicine, University of Yamanashi
-
Maekawa Shinya
First Department Of Internal Medicine University Of Yamanashi
-
Enomoto Nobuyuki
First Department Of Internal Medicine Faculty Of Medicine University Of Yamanashi
-
Maekawa Shinya
First Department Of Internal Medicine Faculty Of Medicine University Of Yamanashi
関連論文
- Enhancement of mitochondrial gene expression in the liver of primary biliary cirrhosis
- Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy
- Griseofulvin, an oral antifungal agent, suppresses hepatitis C virus replication in vitro
- Negative regulation of intracellular hepatitis C virus replication by interferon regulatory factor 3
- Two flavonoids extracts from Glycyrrhizae radix inhibit in vitro hepatitis C virus replication
- Divergent activities of interferon-alpha subtypes against intracellular hepatitis C virus replication
- Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells
- DICKKOPF-4 and -2 genes are upregulated in human colorectal cancer
- Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy
- Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection
- A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysis
- Prolonged treatment with pegylated interferon α 2b plus ribavirin improves sustained virological response in chronic hepatitis C genotype 1 patients with late response in a clinical real-life setting in Japan
- ITPA gene variant protects against anemia induced by pegylated interferon-α and ribavirin therapy for Japanese patients with chronic hepatitis C
- Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C
- Genetic changes in the interferon sensitivity-determining region of hepatitis C virus (HCV) during the natural course of infection : an implication for the gene function in the role of chronic infection
- Magnetic Resonance Elastography for Staging Liver Fibrosis in Chronic Hepatitis C
- MR-based Measurements of Portal Vein Flow and Liver Stiffness for Predicting Gastroesophageal Varices
- Cancer preventive effect of pegylatecl interferon α-2b plus ribavirin in a real-life clinical setting in Japan : PERFECT interim analysis
- Magnetic Resonance Elastography for Staging Liver Fibrosis in Chronic Hepatitis C